DENVER (KDVR) — As many focus on the race to get Coloradans vaccinated against COVID-19, doctors and scientists continue to work to improve treatments for those who contract the virus. Monoclonal Antibody treatment first gained attention last fall as the U.S. Food and Drug Administration issued emergency use authorization to use it to treat mild to moderate cases of COVID-19 in adults. The treatment is more widely available now, according to Dr. Adit Ginde, a University of Colorado School of Medicine faculty member.